|Bid||91.49 x 1000|
|Ask||92.59 x 900|
|Day's Range||91.89 - 92.98|
|52 Week Range||70.89 - 95.72|
|Beta (5Y Monthly)||0.37|
|PE Ratio (TTM)||16.88|
|Forward Dividend & Yield||2.76 (2.98%)|
|Ex-Dividend Date||Jun 14, 2022|
|1y Target Est||N/A|
In the latest trading session, Merck (MRK) closed at $92.51, marking a +0.67% move from the previous day.
Merck (MRK) possesses solid growth attributes, which could help it handily outperform the market.
Seagen (SGEN) is riding on the strong uptake of its marketed drugs that are approved for different cancer indications. Further label expansion of these drugs should boost the top line.